1. Repositorio Digital Universidad De Las Américas
  2. Facultad de Ciencias de la Salud
  3. Escuela de Medicina
  4. Medicina
Por favor, use este identificador para citar o enlazar este ítem: http://dspace.udla.edu.ec/handle/33000/10236
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.advisorGia Bustamante, Jaime Francisco-
dc.creatorLandázuri Navas, Samanta Estefanía-
dc.date.accessioned2018-10-30T15:00:18Z-
dc.date.available2018-10-30T15:00:18Z-
dc.date.issued2018-
dc.identifier.citationLandázuri Navas, S. E. (2018). Diferencias de género y su asociación con la administración de inhibidores de la angiotensina en el tratamiento de la insuficiencia cardíaca descompensada en Puerto Rico (Tesis de pregrado). Universidad de las Américas, Quito.es_ES
dc.identifier.otherUDLA-EC-TMC-2018-09-
dc.identifier.urihttp://dspace.udla.edu.ec/handle/33000/10236-
dc.descriptionIntroduction: In the US, heart failure is a leading cause of attributable cardiovascular disease deaths. Evidence-based guidelines recommend that patients hospitalized with acute decompensated heart failure (ADHF) must receive angiotensin inhibitors (AI), as ACE inhibitors (ACEI)q or AR blockers. The published literature suggests that women with ADHF receive less ACEI than men. Our study focuses on whether there is a gender difference in the recorded administration of AIs in Puerto Rican patients hospitalized with ADHF. Methods: This is a secondary analysis of data from the Puerto Rico Cardiovascular Disease Surveillance System. Adult patients (major 18 years old) hospitalized during study years 2007, 2009, and 2011 with the diagnosis of ADHF (ICD-9 code 428) and without a pacemaker were included for analysis. The association between gender and the medical chart recorded administration of ACEI was assessed using multivariate logistic regression after adjustment for: diabetes, renal failure, hypertension, hyperlipidemia, coronary heart disease, atrial fibrillation, and current smoking status. Statistical significance was defined at an alpha level of 0.05. Results: A total of 1,774 Puerto Rican patients with ADHF were included for analysis; 75.2 equal of which were men. Overall, 75.9 equal of men and 74.5 equal of women received AI (p igual 0.5). The adjusted analysis suggest that no significant gender differences exist in the recorded administration of ACEI (OR igual 0.9; 95 equal CI igual 0.7-1.2) in this population. Although the recorded administration of AI decreased with age in both genders, the difference did not reach statistical significance (p igual 0.06). Conclusion: In contrast with the published literature, our findings suggest that Puerto Rican men and women hospitalized with ADHF have similar odds of receiving ACEI, as recorded in the medical charts. Only three out of four patients received this medication. Further efforts should be implemented to expand the administration of this evidence-based treatment to all patients hospitalized with ADHF.en
dc.description.abstractLa insuficiencia cardíaca, IC, en los Estados Unidos es la primera causa de morbi/mortalidad entre las enfermedades cardiovasculares...es_ES
dc.format.extent47 p.es_ES
dc.language.isospaes_ES
dc.publisherQuito: Universidad de las Américas, 2018es_ES
dc.rightsopenAccesses_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Ecuador*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/ec/*
dc.subjectENFERMEDAD CARDIOVASCULARes_ES
dc.subjectINSUFICIENCIA CARDIACA-TRATAMIENTOes_ES
dc.subjectSISTEMA CARDIOVASCULARes_ES
dc.titleDiferencias de género y su asociación con la administración de inhibidores de la angiotensina en el tratamiento de la insuficiencia cardíaca descompensada en Puerto Ricoes_ES
dc.typebachelorThesises_ES
Aparece en las colecciones: Medicina

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
UDLA-EC-TMC-2018-09.pdf1,65 MBAdobe PDFVisualizar/Abrir
Mostrar el registro sencillo del ítem


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons